G. Eric Davis

G. Eric Davis

Executive Vice President, Chief Legal OfficeratBiomarin Pharmaceutical· In proxies 2022–2024

Pay in FY2024+9% from the year before · Biomarin Pharmaceutical stock -31.8% the same year

G. Eric Davis was paid $5.1M in FY2024 (Dec), up 9%. Biomarin Pharmaceutical stock fell 31.8% that year.

Pay$100 in the stock at the end of FY21 → $74
Pay is from the Summary Compensation Table of each Biomarin Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Biomarin PharmaceuticalPublic company · 4 yr
    • Executive Vice President, Chief Legal Officer2022 – Present · 4 yrStock in role -38%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?